Author: Moore on Health™

As a Nurse Practitioner I am delivering healthcare services, namely, providing evidenced based health promotion, primary prevention, disease and medical practice management.

By on

Moore Harvest PhotoMoore On Health (MOH) believes that the human body is a dynamic vehicle. Therefore, your eating lifestyle needs to be comparable in order to achieve your optimal level of health and wellness.

MOH recommends that choosing a balanced eating plan packed with fruits and vegetables will allow you to begin or sustain your healthy lifestyle journey.

 

WE ARE SOLD OUT 

CHECK BACK FOR MOORE HARVEST 

SELECTIONS IN 2-3 WEEKS

You will find below a link allowing you to purchase (when available) Fresh Fruits, Herbs and coming soon Vegetables such as:

  • Avocados AAC box

  • Fuji Pear                                                             

  • Mandarin Oranges 
  • Naval Oranges 
  • Figs
  • Apricots
  • Lemons
  • Plums
  • Persimmons
  • Paw Paw fruit (coming soon)
  • Thyme
  • Rosemary 
    • Basil  Moore Harvest part 2
    • Kale (coming soon)
    • Tomatoes (coming soon)
    • Cucumbers (coming soon)
    • Garlic (coming soon)
    • Scallions (coming soon)
    • Broccoli (coming soon

    Research is readily available outlining the benefits that fruits and vegetables can provide the following:

    • Prevention of Cancer
    • Prevention of coronary heart disease
    • Protective role in stroke
    • Prevention of cataract formation
    • Prevention of chronic obstructive pulmonary disease (COPD)
    • Prevention of diverticulosis

    The Moore Harvest program wants to provide people with the opportunity to increase their consumption of powerhouse vegetables and fruits. MOH believes in continuing the attention to empower the community at large about utilizing and maintaining a nutritional intake promoting a reduction in disease risk and maximize good health.

    Information for placing an order is listed below. The cost covers shipping, packaging and minimally assists MOH in maintaining an organic farming system – allowing the Moore Harvest program to be chemical free.

    • Send an email to mooreonhealth@gmail.com and be sure to include the following information:
    • Your Name, Address and Contact Number
    • Type of fruit, herb and/or vegetable (Request items that are labeled AVAILABLE)
    • WAIT TO RECEIVE YOUR CONFIRMATION NUMBER BEFORE MAKING A PAYMENT
    • For deliveries made in CALIFORNIA ONLY make a payment of $25.00 by clicking on this PayPal icon                             

      WE ARE SOLD OUT 

      CHECK BACK FOR MOORE HARVEST 

      SELECTIONS IN 2-3 WEEKS

    • You will receive a 8”x11”x4” box weighing approximately six pounds filled with your selected item(s). 
    • Deliveries outside of California will a require you to FIRST contact Moore On Health at 805-729-6919

    THERE ARE NO REFUNDS

    From Our Trees To Your Table 

    Moore Harvest

    table shipment MH

By on

An Unforeseen Complication of the New Hepatitis C Drugs

Abigail Zuger, MD reviewing  Collins JM et al.  Clin Infect Dis 2015 Oct 15.  Balagopal A and Thio CL.  Clin Infect Dis 2015 Oct 15. 

Hepatitis B might flare during treatment for hepatitis C.

Effective and nontoxic new drugs for eradicating hepatitis C virus (HCV) have inspired a well-deserved wave of enthusiasm among clinicians. However, an intriguing pair of case reports suggests these drugs should be used with caution in HCV-positive patients who also are infected with hepatitis B virus (HBV). These two patients, HIV-negative men in their mid-50s, had chronic HBV and HCV genotype 1a infections; HCV treatment with peginterferon plus ribavirin had failed.

One patient had barely detectable HBV DNA (2300 IU/mL) at the beginning HCV treatment with sofosbuvir (Sovaldi) and simeprevir (Olysio). By week 4 after the start of treatment, HCV viral load was undetectable. At week 7, jaundice, abdominal pain, and other evidence of severe viral hepatitis developed; HCV RNA remained undetectable, but HBV DNA was 22 million IU/mL. HCV treatment was stopped, and HBV treatment with combination tenofovir and emtricitabine was begun. At week 28, the patient was well, and neither virus was detectable in his blood.

In the other patient, HBV viral load was monitored from the outset of treatment with sofosbuvir and simeprevir. HBV DNA was undetectable prior to treatment but rose to 11,255 IU/mL by week 4. Although the patient remained asymptomatic, tenofovir was added to the treatment regimen, and both viruses were undetectable at week 12.

 

#HepatitisC #HCVTreatment #HepatitisB #HepatitisBTreatment #NursePractitioner #MedicalProvider #NPLeader #MooreOnHealth

– See more at: http://www.jwatch.org/na39275/2015/10/08/unforeseen-complication-new-hepatitis-c-drugs?ijkey=w7CHfu7thGeSQ&keytype=ref&siteid=jwatch&query=pfw-featured&variant=full-text#sthash.t7QxCDn5.dpuf